Guyana vs Latvia: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Guyana
99.0%
in 2025
Latvia
99.0%
in 2025
Guyana rank
1st
Latvia rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Guyana
- Latvia
How they compare
Guyana currently reports 99.0% against 99.0% in Latvia, a difference of 0.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was Latvia ahead.
Guyana ranks 1st and Latvia ranks 1st of 194 countries.
Across the 3 decades both report, Guyana averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Guyana | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.6% | 96.4% | 4.8% | Latvia |
| 2010s | 96.4% | 94.6% | 1.8% | Guyana |
| 2020s | 98.8% | 97.0% | 1.8% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Guyana or Latvia?
- Guyana, at 99.0% against 99.0% in Latvia as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Guyana and Latvia?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Latvia?
- 26 years are reported by both, from 2000 to 2025.
- How do Guyana and Latvia rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Guyana ranks 1st and Latvia ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.